Literature DB >> 19497443

Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).

Jolanta Klovaite1, Finn Gustafsson, Svend A Mortensen, Kåre Sander, Lars B Nielsen.   

Abstract

OBJECTIVES: This study investigated the influence of the mechanical blood pump HeartMate II (HMII) (Thoratec Corporation, Pleasanton, California) on blood coagulation and platelet function.
BACKGROUND: HMII is an implantable left ventricular assist device used for the treatment of heart failure. Patients treated with HMII have increased bleeding tendencies.
METHODS: We measured agonist-induced platelet aggregation in 16 patients on HMII support.
RESULTS: The von Willebrand factor (vWF)-dependent ristocetin-induced platelet aggregation was impaired in 11 of the 16 patients, of which 12 had experienced at least 1 minor or major bleeding episode. The impaired ristocetin-induced platelet aggregation was associated both with decreased specific activity of plasma vWF, presumably due to lack of high molecular weight vWF multimers, as well as with attenuated function of the platelets themselves.
CONCLUSIONS: The results imply that HMII treatment is associated with impaired platelet aggregation, which may contribute to an increased tendency to bleed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497443     DOI: 10.1016/j.jacc.2009.02.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  48 in total

1.  We always need a pulse, or do we??

Authors:  Leslie Miller
Journal:  J Cardiovasc Transl Res       Date:  2012-05-03       Impact factor: 4.132

Review 2.  Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets.

Authors:  Antigone Koliopoulou; Stephen H McKellar; Matthew Rondina; Craig H Selzman
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

Review 3.  Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.

Authors:  Ashrith Guha; Carrie L Eshelbrenner; David M Richards; Howard P Monsour
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jan-Mar

4.  Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy?

Authors:  Snehal R Patel; Sasa Vukelic; Ulrich P Jorde
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

5.  Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.

Authors:  Brian Paul Selgrade; George A Truskey
Journal:  Artif Organs       Date:  2012-02-23       Impact factor: 3.094

Review 6.  Coagulopathy in Mechanical Circulatory Support: A Fine Balance.

Authors:  Julie L Rosenthal; Randall C Starling
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

7.  Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices.

Authors:  Nandan K Mondal; Tieluo Li; Zengsheng Chen; Hegang H Chen; Erik N Sorensen; Si M Pham; Michael A Sobieski; Steven C Koenig; Mark S Slaughter; Bartley P Griffith; Zhongjun J Wu
Journal:  Mol Cell Biochem       Date:  2017-03-25       Impact factor: 3.396

Review 8.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

9.  Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices.

Authors:  Angelo Nascimbene; Ruben Hernandez; Joggy K George; Anita Parker; Angela L Bergeron; Subhashree Pradhan; K Vinod Vijayan; Andrew Civitello; Leo Simpson; Maria Nawrot; Vei-Vei Lee; Hari R Mallidi; Reynolds M Delgado; Jing Fei Dong; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2014-01-19       Impact factor: 10.247

10.  Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.

Authors:  Castigliano M Bhamidipati; Gorav Ailawadi; James Bergin; John A Kern
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-27       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.